Preclinical molecule development is a fundamental step in bringing novel therapies to patients. Enhancing the performance of these medicines requires detailed understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a extensive range of assays designed to define the fate and mec